| Application no. and date | 00988803.3 (espacenet) (Federated) (European Patent Register), 20001219 | | Patent/reg. no. and date | DK/EP 1239832, 20040623 | | Publication date | 20020918 | | Priority no. and date | GB 9930058, 19991220 | | EP pub. no. and date |
EP 1239832 20020918 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 119449 | | Inventor | SIGG, Juergen, Karl-Arzet-Weg 25
79540 Loerrach, DE,
BILLINGTON, Michael, Rudolf Wackernagel Strasse 41
CH-4125 Riehen, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K, DK | | Opponent | | | IPC Class | A61K 31/55, A61K 9/10 | | Title | Suspension omfattende oxcarbazepin | | Int. application no. | EP2000012968 | | Int. publication no. | WO2001045671 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
